Abstract
Advances in cell biology have encouraged the hope that stem cell-based therapy can be used to heal central nervous system (CNS) diseases. Here, we will review the potential application of neural cell transplantation for the treatment of multiple sclerosis (MS) and other demyelinating disorders, mention some problematic issues that still face this therapeutic approach, and describe novel noninvasive methods for in vivo tracking of transplanted cells.
Keywords: inflammatory disease, experimental autoimmune encephalomyelitis, immunosuppressive, plp gene, picornavirus, ependymal cells
Current Drug Targets
Title: Stem Cell Therapy for Myelin Diseases
Volume: 6 Issue: 1
Author(s): Tamir Ben-Hur, Ofira Einstein and Jeff W.M. Bulte
Affiliation:
Keywords: inflammatory disease, experimental autoimmune encephalomyelitis, immunosuppressive, plp gene, picornavirus, ependymal cells
Abstract: Advances in cell biology have encouraged the hope that stem cell-based therapy can be used to heal central nervous system (CNS) diseases. Here, we will review the potential application of neural cell transplantation for the treatment of multiple sclerosis (MS) and other demyelinating disorders, mention some problematic issues that still face this therapeutic approach, and describe novel noninvasive methods for in vivo tracking of transplanted cells.
Export Options
About this article
Cite this article as:
Ben-Hur Tamir, Einstein Ofira and Bulte W.M. Jeff, Stem Cell Therapy for Myelin Diseases, Current Drug Targets 2005; 6 (1) . https://dx.doi.org/10.2174/1389450053345000
DOI https://dx.doi.org/10.2174/1389450053345000 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Current Pharmaceutical Design “Metabolic Aspects” In Inflammatory Bowel Diseases
Current Drug Delivery Recent Applications of Birch Reduction in Total Synthesis of Natural Products
Current Organic Chemistry Emerging Role of Regulatory T Cells in Gene Transfer
Current Gene Therapy Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures
Current Topics in Medicinal Chemistry Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β
CNS & Neurological Disorders - Drug Targets Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy Matrine: Bioactivities and Structural Modifications
Current Topics in Medicinal Chemistry Fluorescent Substrates Useful as High Throughput Screening Tools for ADAM9
Combinatorial Chemistry & High Throughput Screening ADAM8 in Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Immune Regulation by the Posttranslational Modification O-GlcNAc
Current Signal Transduction Therapy NKT Cell-Stimulating Synthetic Glycolipids as Potential Therapeutics for Autoimmune Disease
Current Topics in Medicinal Chemistry Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review
Current Drug Safety Therapeutic Manipulation of the Immune System: Enhancement of Innate and Adaptive Mucosal Immunity
Current Pharmaceutical Design Distinct Functions of Interleukin-10 Derived from Different Cellular Sources
Current Immunology Reviews (Discontinued) A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
CNS & Neurological Disorders - Drug Targets Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research